Dr. O'Connor is medically (Leicester) and PhD (Imperial) qualified and currently the Director Regulatory and Early Access Policy at The Association of the British Pharmaceutical Industry (ABPI). He joined the ABPI from the Medicines and Healthcare products Regulatory Agency in 2023. At the MHRA he was Deputy Director of the Innovation Accelerator and Regulatory Science. Dan has special interests in drug development, rare diseases, regulatory science, early access, health innovation, patient engagement and drug repurposing. He completed higher medical training in Pharmaceutical Medicine.   He is Editor-Author of the Oxford Specialist Handbook in Pharmaceutical Medicine.